Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma.
about
Therapy-related myeloid neoplasms - what have we learned so far?National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent NeoplasmsT cell-prolymphocytic leukemia detected in a patient of breast cancer at the time of recurrence: a case reportProgeroid syndromes: models for stem cell aging?Bone marrow failure and the telomeropathies.Haematopoietic stem and progenitor cells in rheumatoid arthritisThe role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantationSecondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in miceLong-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor StudyGranulocytes affect double-strand break repair assays in primary human lymphocytes.Telomere length in myelodysplastic syndromes.Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.Similarities and differences between therapy-related and elderly acute myeloid leukemia.Telomere diseasesTreatment-related myelodysplastic syndrome: molecular characteristics and therapyAge-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.Telomere dynamics in mice and humansLong-term follow up of patients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AMLTherapy-related myelodysplasia and acute myeloid leukemiaTherapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Secondary cancers following allogeneic haematopoietic cell transplantation in adults.Telomere dysfunction and its role in haematological cancer.Therapy-related myelodysplastic syndrome.Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.Secondary Adult Acute Myeloid Leukemia: a Review of Our Evolving Understanding of a Complex Disease Process.Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.Telomere length is an independent prognostic marker in MDS but not in de novo AML.Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.Epstein-Barr virus-positive diffuse large B-cell lymphoma following acute myeloid leukemia: a common clonal origin indicated by chromosomal translocation t(3;4)(p25;q21).Blood Telomere Length Attrition and Cancer Development in the Normative Aging Study Cohort.Progressive genomic instability in the Nup98-HoxD13 model of MDS correlates with loss of the PIG-A gene productThe effect of chemotherapy on telomere dynamics: clinical results and possible mechanisms.Clonality in context: hematopoietic clones in their marrow environment.Shortened telomeres: a driving force behind leukemia?The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature
P2860
Q28071318-66C3759D-C5BF-413E-8EE1-D2822A5FC9AEQ29248394-DFF9FA16-E199-494B-A5CD-6405E913D08AQ33592181-906D9185-F53D-485F-BBE7-6CC8BE211DFCQ34198784-F9299161-F1DD-42F6-A19C-4E922A336669Q34431411-DB44EEF1-BEE4-4C28-B950-C6B92C34A744Q34495902-B36D092F-5ABA-4150-9CA0-ABD962977421Q34544862-35E48689-F2DC-44BF-813E-4960E2B74199Q34568905-A843095C-9333-4A2B-900B-30FEE76664E5Q34737496-E3FE4B51-FD00-471E-8E08-952E535CB2C4Q35067402-9DF6DA9D-3DB2-4B66-9F58-7AE9A6C6119CQ35131489-175B894E-8EC7-4F50-8E4A-A8CB39D5DEB2Q35150727-F79CB4A2-C33E-4AD2-B69C-BFE633D295F9Q35563771-16CD19ED-FF69-4BC1-89FD-D0989899D2BAQ35640731-C18C543F-4CA9-450C-BE95-26855174AE94Q36107376-E9EE1AFA-A2ED-4177-9436-D6353FCF0838Q36219790-DAD63845-F8EF-493F-AE0A-48B1B2CB2F9BQ36333552-BB143CFE-B383-409D-9EE8-EDAB168045EFQ37091301-D023BD8E-CCB8-4171-A26C-8A493A89838CQ37173297-4CD86043-19DF-47AF-BB98-9187B54975ECQ37402657-B158DF90-7BE9-4A13-A0D1-9FBE7B0654D3Q37548821-8983A241-DB69-4BF0-8C46-92B43B2E5D00Q37621379-58A47E87-477C-4D28-95C5-AF4FD21BD27FQ37880254-FFBDC3AC-84E4-42D8-B665-8FE9AE5875FEQ37974664-850C15B1-5401-4797-BD4E-05CDB664664FQ38353167-D45A79A7-9C71-460D-A883-BFACCE591A95Q38407872-69C089A6-54B4-4C3A-B6F7-1E41E6634DDFQ38542828-FCDD9C89-5EA0-4A0C-823D-D4C3307761DDQ38628809-536BD393-7977-48E7-A90D-CC4694838F46Q40208892-51A21C16-13E4-4C07-A0EA-EB3B4F0D3D20Q40722671-156758A2-E6B9-44B7-A106-32DA3ED215DDQ40962969-58C1501B-3DFA-49D4-B76A-6660B91DAB07Q41470134-A4CB1D8F-9A39-4D3A-B0AB-89F6A2C5FC19Q42681933-E4714325-D773-4199-B5AA-4111BD2FC5F9Q44800699-35A84F45-8D7D-4C21-998E-CC0C2C0956A6Q50091222-F5770997-6D1D-41C1-BAAD-469B5E488C1FQ51773652-720FCECF-83E5-4728-8C95-045E8CD7D2C0Q57067048-44011616-054B-4FBD-BA18-84784E79A5CF
P2860
Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Accelerated telomere shortenin ...... transplantation for lymphoma.
@en
Accelerated telomere shortenin ...... transplantation for lymphoma.
@nl
type
label
Accelerated telomere shortenin ...... transplantation for lymphoma.
@en
Accelerated telomere shortenin ...... transplantation for lymphoma.
@nl
prefLabel
Accelerated telomere shortenin ...... transplantation for lymphoma.
@en
Accelerated telomere shortenin ...... transplantation for lymphoma.
@nl
P2093
P2860
P356
P1476
Accelerated telomere shortenin ...... transplantation for lymphoma.
@en
P2093
Can-Lan Sun
Karen L Chang
Liton Francisco
Melanie Sabado
Ravi Bhatia
Smita Bhatia
Stephen Forman
Sujata Chakraborty
P2860
P304
P356
10.1200/JCO.2008.17.1033
P407
P577
2009-01-05T00:00:00Z